Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic biology without original human data or systematic review methodology.
PubMed 40728970 · doi:10.3390/cimb47070501
What was done
This is a narrative review summarizing the molecular and physiological mechanisms of the renin-angiotensin-aldosterone system (RAAS), focusing on the dual pathogenic and protective pathways of angiotensin II receptors (AT1R and AT2R) and the ACE2 axis in cardiovascular pathology and ageing.
What was found
The abstract reports no quantitative numbers or statistics. It describes mechanistic pathways: AT1R activation mediates vasoconstriction, oxidative stress, endothelial dysfunction, peripheral vascular resistance, atherosclerosis, and cellular senescence. In contrast, AT2R activation counteracts these processes by inducing vascular relaxation and attenuating cell proliferation and migration. Additionally, ACE2-mediated conversion into angiotensin (1-7) and angiotensin (1-9) is described as conferring cardiovascular protection by reducing oxidative stress, inflammation, and abnormal cell growth.
Why it matters
It synthesizes the mechanistic balance between deleterious AT1R signaling and protective AT2R/ACE2 pathways, supporting the biological rationale behind antihypertensive therapies targeting RAAS.
Limits
The paper is a narrative overview rather than an empirical study or systematic review, offering no original experimental data, human sample sizes, or quantitative effect sizes.
Cited by
- supports ACE2 balances angiotensin II and angiotensin-(1-7), reducing pro-oxidative products and increasing antioxidant products.